247 related articles for article (PubMed ID: 30559069)
1. Therapeutic Delivery of miR-148a Suppresses Ventricular Dilation in Heart Failure.
Raso A; Dirkx E; Philippen LE; Fernandez-Celis A; De Majo F; Sampaio-Pinto V; Sansonetti M; Juni R; El Azzouzi H; Calore M; Bitsch N; Olieslagers S; Oerlemans MIFJ; Huibers MM; de Weger RA; Reckman YJ; Pinto YM; Zentilin L; Zacchigna S; Giacca M; da Costa Martins PA; López-Andrés N; De Windt LJ
Mol Ther; 2019 Mar; 27(3):584-599. PubMed ID: 30559069
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.
Verjans R; Peters T; Beaumont FJ; van Leeuwen R; van Herwaarden T; Verhesen W; Munts C; Bijnen M; Henkens M; Diez J; de Windt LJ; van Nieuwenhoven FA; van Bilsen M; Goumans MJ; Heymans S; González A; Schroen B
Hypertension; 2018 Feb; 71(2):280-288. PubMed ID: 29255073
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling.
Karakikes I; Chaanine AH; Kang S; Mukete BN; Jeong D; Zhang S; Hajjar RJ; Lebeche D
J Am Heart Assoc; 2013 Apr; 2(2):e000078. PubMed ID: 23612897
[TBL] [Abstract][Full Text] [Related]
4. Intravenous miR-144 reduces left ventricular remodeling after myocardial infarction.
Li J; Cai SX; He Q; Zhang H; Friedberg D; Wang F; Redington AN
Basic Res Cardiol; 2018 Aug; 113(5):36. PubMed ID: 30084039
[TBL] [Abstract][Full Text] [Related]
5. Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction.
Norton GR; Woodiwiss AJ; Gaasch WH; Mela T; Chung ES; Aurigemma GP; Meyer TE
J Am Coll Cardiol; 2002 Feb; 39(4):664-71. PubMed ID: 11849866
[TBL] [Abstract][Full Text] [Related]
6. Exposure to chronic alcohol accelerates development of wall stress and eccentric remodeling in rats with volume overload.
Mouton AJ; Ninh VK; El Hajj EC; El Hajj MC; Gilpin NW; Gardner JD
J Mol Cell Cardiol; 2016 Aug; 97():15-23. PubMed ID: 27107489
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte-specific miR-100 overexpression preserves heart function under pressure overload in mice and diminishes fatty acid uptake as well as ROS production by direct suppression of Nox4 and CD36.
Smolka C; Schlösser D; Koentges C; Tarkhnishvili A; Gorka O; Pfeifer D; Bemtgen X; Asmussen A; Groß O; Diehl P; Moser M; Bode C; Bugger H; Grundmann S; Pankratz F
FASEB J; 2021 Nov; 35(11):e21956. PubMed ID: 34605573
[TBL] [Abstract][Full Text] [Related]
8. Detailed characterization of microRNA changes in a canine heart failure model: Relationship to arrhythmogenic structural remodeling.
Chen Y; Wakili R; Xiao J; Wu CT; Luo X; Clauss S; Dawson K; Qi X; Naud P; Shi YF; Tardif JC; Kääb S; Dobrev D; Nattel S
J Mol Cell Cardiol; 2014 Dec; 77():113-24. PubMed ID: 25315712
[TBL] [Abstract][Full Text] [Related]
9. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
[TBL] [Abstract][Full Text] [Related]
10. Cardiac hypertrophy and dysfunction induced by overexpression of miR-214 in vivo.
Yang T; Gu H; Chen X; Fu S; Wang C; Xu H; Feng Q; Ni Y
J Surg Res; 2014 Dec; 192(2):317-25. PubMed ID: 25085702
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol.
Nishiga M; Horie T; Kuwabara Y; Nagao K; Baba O; Nakao T; Nishino T; Hakuno D; Nakashima Y; Nishi H; Nakazeki F; Ide Y; Koyama S; Kimura M; Hanada R; Nakamura T; Inada T; Hasegawa K; Conway SJ; Kita T; Kimura T; Ono K
Circ Res; 2017 Mar; 120(5):835-847. PubMed ID: 27920122
[TBL] [Abstract][Full Text] [Related]
12. Myocardial microRNAs associated with reverse remodeling in human heart failure.
Sucharov CC; Kao DP; Port JD; Karimpour-Fard A; Quaife RA; Minobe W; Nunley K; Lowes BD; Gilbert EM; Bristow MR
JCI Insight; 2017 Jan; 2(2):e89169. PubMed ID: 28138556
[TBL] [Abstract][Full Text] [Related]
13. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.
Duisters RF; Tijsen AJ; Schroen B; Leenders JJ; Lentink V; van der Made I; Herias V; van Leeuwen RE; Schellings MW; Barenbrug P; Maessen JG; Heymans S; Pinto YM; Creemers EE
Circ Res; 2009 Jan; 104(2):170-8, 6p following 178. PubMed ID: 19096030
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Silencing of MicroRNA-152 Prevents Pressure Overload-Induced Heart Failure.
LaRocca TJ; Seeger T; Prado M; Perea-Gil I; Neofytou E; Mecham BH; Ameen M; Chang ACY; Pandey G; Wu JC; Karakikes I
Circ Heart Fail; 2020 Mar; 13(3):e006298. PubMed ID: 32160771
[TBL] [Abstract][Full Text] [Related]
15. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
16. Chronic treatment of mice with leukemia inhibitory factor does not cause adverse cardiac remodeling but improves heart function.
Zgheib C; Zouein FA; Kurdi M; Booz GW
Eur Cytokine Netw; 2012; 23(4):191-7. PubMed ID: 23291613
[TBL] [Abstract][Full Text] [Related]
17. Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy.
Matkovich SJ; Hu Y; Eschenbacher WH; Dorn LE; Dorn GW
Circ Res; 2012 Aug; 111(5):521-31. PubMed ID: 22752967
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21-Dependent Macrophage-to-Fibroblast Signaling Determines the Cardiac Response to Pressure Overload.
Ramanujam D; Schön AP; Beck C; Vaccarello P; Felician G; Dueck A; Esfandyari D; Meister G; Meitinger T; Schulz C; Engelhardt S
Circulation; 2021 Apr; 143(15):1513-1525. PubMed ID: 33550817
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease.
Martinez EC; Lilyanna S; Wang P; Vardy LA; Jiang X; Armugam A; Jeyaseelan K; Richards AM
J Mol Cell Cardiol; 2017 Nov; 112():27-39. PubMed ID: 28865712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
